Signpost India Files Regulatory Disclosure for Second 100 Days Saksham Niveshak Campaign

1 min read     Updated on 29 Apr 2026, 04:21 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Signpost India Limited has filed a regulatory disclosure for the Second 100 Days Campaign 'Saksham Niveshak' scheduled from April 1, 2026 to July 9, 2026, following IEPFA directive. The campaign enables shareholders to update KYC details and claim unclaimed dividends through specific forms (ISR-1, ISR-2, SH-13, ISR-3) via physical or digital submission to KFIN Technologies Limited.

powered bylight_fuzz_icon
38960243

*this image is generated using AI for illustrative purposes only.

Signpost India Limited has filed a regulatory disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the Second 100 Days Campaign - "Saksham Niveshak" scheduled from April 1, 2026 to July 9, 2026. The campaign follows a directive from the Investor's Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs.

Campaign Objectives and Timeline

The IEPFA has requested companies to launch this initiative to enhance investor awareness by helping shareholders update their KYC details, contact information, and bank mandates. The campaign aims to facilitate direct payment of unclaimed and unpaid dividends to rightful shareholders before they get transferred to the Investor Education and Protection Fund (IEPF).

Campaign Parameters: Details
Duration: April 1, 2026 to July 9, 2026
Authority: IEPFA, Ministry of Corporate Affairs
Campaign Name: Second 100 Days Campaign 'Saksham Niveshak'

Shareholder Action Requirements

Shareholders whose dividends have remained unpaid or unclaimed, or those who are non-KYC compliant, are requested to update their details including PAN, email address, contact number, address, bank account details, specimen signature, and nomination. The company has designated KFIN Technologies Limited as the Registrar and Transfer Agent (RTA).

Document Submission Requirements

The company has outlined specific documentation requirements for shareholders to complete their KYC updates and claim unpaid dividends:

Required Forms: Details
Form ISR-1: Filled and signed, with self-attested KYC documents
Form ISR-2: Filled and signed, with banker's attestation of signature + original cancelled cheque or self-attested bank passbook/statement
Form SH-13: For adding a nominee
Form ISR-3: If opting out of nomination

Submission Procedures

Shareholders can submit their documents through multiple channels to ensure convenience and accessibility:

Physical Submission:

  • Send physical copies, self-attested and dated to KFIN Technologies Limited
  • Address: Selenium Tower B, Plot Nos. 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad - 500032

Digital Submission:

Compliance and Benefits

The disclosure emphasizes the importance of timely action to prevent transfer of unclaimed dividends to IEPF and ensures shareholders receive their rightful dividends directly to their bank accounts. This regulatory initiative helps maintain updated shareholder records and facilitates seamless dividend distribution processes.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.47%+11.20%+40.87%+12.32%+5.38%+89.65%

How might the success rate of this second campaign compare to the first 'Saksham Niveshak' initiative in terms of shareholder participation and dividend recovery?

What impact could widespread adoption of similar KYC update campaigns across listed companies have on the overall size of the IEPF corpus?

Will SEBI consider making such investor awareness campaigns mandatory for all listed companies with significant unclaimed dividend amounts?

Neogen Chemicals Subsidiary Approves Rs 100.11 Crore Rights Issue for Battery Materials Expansion

2 min read     Updated on 29 Apr 2026, 02:08 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Neogen Ionics Limited, a wholly owned subsidiary of Neogen Chemicals Limited, has approved subscription of 71,00,000 equity shares in step-down subsidiary Neogen Morita New Material Limited through a rights issue worth Rs 100,11,00,000. The shares will be issued at Rs 141 per share with a face value of Rs 10 each. Neogen Morita simultaneously increased its authorized capital from Rs 5,00,00,000 to Rs 9,90,00,000 to accommodate the issue. The funds will support salt business acquisition, CAPEX/OPEX requirements, and general corporate purposes for the lithium-ion battery materials focused company incorporated in July 2025.

powered bylight_fuzz_icon
38954328

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited's subsidiary structure has witnessed a significant capital infusion as Neogen Ionics Limited approved a substantial rights issue subscription in its step-down subsidiary. The Board of Directors of Neogen Ionics Limited, a wholly owned subsidiary of Neogen Chemicals Limited, approved the subscription of equity shares in Neogen Morita New Material Limited on April 28, 2026.

Rights Issue Details

The rights issue involves the subscription of up to 71,00,000 equity shares with specific terms and conditions designed to strengthen the subsidiary's capital base.

Parameter Details
Number of Shares 71,00,000 equity shares
Face Value Rs 10 per share
Issue Price Rs 141 per share
Total Amount Rs 100,11,00,000
Issue Type Rights basis

Capital Structure Enhancement

Neogen Morita New Material Limited has simultaneously approved an increase in its authorized share capital to accommodate the rights issue. The Board of NML, subject to shareholder approval, has approved significant changes to its capital structure.

Capital Component Previous Revised
Authorized Capital Rs 5,00,00,000 Rs 9,90,00,000
Number of Shares 50,00,000 shares 99,00,000 shares
Current Paid-up Capital Rs 10,00,000 Rs 10,00,000

Business Objectives and Fund Utilization

The funds raised through this rights issue will serve multiple strategic purposes for Neogen Morita New Material Limited. The company plans to utilize the capital for acquiring salt business operations, meeting both capital expenditure and operational expenditure requirements, and pursuing other general corporate purposes as determined by the Board in compliance with applicable laws.

Company Background and Strategic Focus

Neogen Morita New Material Limited, incorporated on July 30, 2025, operates as an unlisted public limited company under Indian laws. The company maintains its registered office at Dev Corpora Building, Thane, Maharashtra, and focuses specifically on growth opportunities in the lithium-ion battery material space.

The company's primary business objective centers on electrolyte salts production, addressing both internal consumption requirements for electrolytes and meeting global market demand in the rapidly expanding battery materials sector.

Transaction Structure and Compliance

This acquisition falls under the category of related party transactions between Neogen Ionics Limited and Neogen Morita New Material Limited, both subsidiaries of Neogen Chemicals Limited. The transaction is exempted under regulation 23 of Listing regulations and section 188 of the Companies Act, 2013. The subscription and allotment process is expected to be completed within 60 days from the date of receipt of share application money by NML from NIL, with the consideration being entirely cash-based.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.47%+11.20%+40.87%+12.32%+5.38%+89.65%

How will this significant capital infusion position Neogen Morita to compete in the rapidly growing global lithium-ion battery materials market?

What specific salt business operations is the company targeting for acquisition, and how might this impact their market share in electrolyte salts production?

Could this Rs 100+ crore investment signal Neogen Chemicals' broader strategy to expand its presence in the EV battery supply chain ecosystem?

More News on Neogen Chemicals

1 Year Returns:+5.38%